In vitro release of cisplatin from sol–gel processed organically modified silica xerogels

被引:0
|
作者
Katarzyna Czarnobaj
Jerzy Łukasiak
机构
[1] Medical University of Gdansk,Department of Physical Chemistry with Laboratory of Instrumental Analysis
关键词
Drug Release; PDMS; Simulated Body Fluid; Redistilled Water; Silica Xerogel;
D O I
暂无
中图分类号
学科分类号
摘要
SiO2, SiO2/PEG and SiO2/PDMS xerogels were examined as polymeric carriers for the controlled release of cisplatin—an antineoplasmic medicine. Drug/carrier systems were prepared by the sol–gel method. The effect of organic substitution of the silica xerogel matrix and drying conditions on the release of cisplatin was evaluated. Based on the presented results of the study it may be stated that sol–gel method is useful for entrapping a cisplatin in the pores of organically modified silica gels and for releasing cisplatin mainly in the way of diffusion from the pores of the lattice under the in vitro conditions. The use of organic impurities in silica gel increased the release of cisplatin from xerogel (from 62% to 97% within 7 days), and thermal treatment of all xerogels with cisplatin at the temperature of 80 °C resulted in the acceleration of the drug release (2 days) and increase of the released drug (89–98%).
引用
收藏
页码:2041 / 2044
页数:3
相关论文
共 50 条
  • [1] In vitro release of cisplatin from sol-gel processed organically modified silica xerogels
    Czarnobaj, Katarzyna
    Lukasiak, Jerzy
    JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2007, 18 (10) : 2041 - 2044
  • [2] In vitro release of cisplatin from sol-gel processed porous silica xerogels
    Czarnobaj, K
    Lukasiak, J
    DRUG DELIVERY, 2004, 11 (06) : 341 - 344
  • [3] In vitro release behavior of toremifene citrate from sol-gel processed sintered silica xerogels
    Ahola, M
    Kortesuo, P
    Kangasniemi, I
    Kiesvaara, J
    Yli-Urpo, A
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (08) : 955 - 959
  • [4] SANS experiments in organically modified silica xerogels
    Cavatorta, F
    Cauzzi, DA
    Predieri, G
    PHYSICA B, 1997, 234 : 396 - 398
  • [5] In vitro release of heparin from silica xerogels
    Ahola, MS
    Säilynoja, ES
    Raitavuo, MH
    Vaahtio, MM
    Salonen, JI
    Yli-Urpo, AUO
    BIOMATERIALS, 2001, 22 (15) : 2163 - 2170
  • [6] Modified sol–gel processed silica matrix for gel electrophoresis applications
    Madhusudhan M. Nadgir
    Austin Coffey
    Bhaskar Mohan Murari
    Journal of Sol-Gel Science and Technology, 2017, 83 : 155 - 164
  • [7] The controlled release of drugs from emulsified, sol gel processed silica microspheres
    Radin, Shula
    Chen, Tiffany
    Ducheyne, Paul
    BIOMATERIALS, 2009, 30 (05) : 850 - 858
  • [8] The effect of PEG concentration on the release rate of cisplatin from PEG-modified silica xerogels
    Czarnobaj, Katarzyna
    Prokopowicz, Magdalena
    Lukasiak, Jerzy
    DRUG DELIVERY, 2006, 13 (05) : 339 - 344
  • [9] Modified sol-gel processed silica matrix for gel electrophoresis applications
    Nadgir, Madhusudhan M.
    Coffey, Austin
    Murari, Bhaskar Mohan
    JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY, 2017, 83 (01) : 155 - 164
  • [10] Correlation between heparin release and polymerization degree of organically modified silica xerogels from 3-methacryloxypropylpolysilsesquioxane
    Tebbe, David
    Thull, Roger
    Gbureck, Uwe
    ACTA BIOMATERIALIA, 2007, 3 (06) : 829 - 837